Organoids: The current status and biomedical applications

S Yang, H Hu, H Kung, R Zou, Y Dai, Y Hu… - MedComm, 2023 - Wiley Online Library
Organoids are three‐dimensional (3D) miniaturized versions of organs or tissues that are
derived from cells with stem potential and can self‐organize and differentiate into 3D cell …

[HTML][HTML] Human 3D brain organoids: steering the demolecularization of brain and neurological diseases

YK Adlakha - Cell Death Discovery, 2023 - nature.com
Understanding of human brain development, dysfunction and neurological diseases has
remained limited and challenging due to inability to recapitulate human brain-specific …

[HTML][HTML] Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model

Z Liu, J Chao, C Wang, G Sun, D Roeth, W Liu, X Chen… - Cell reports, 2023 - cell.com
The C allele of rs11136000 variant in the clusterin (CLU) gene represents the third strongest
known genetic risk factor for late-onset Alzheimer's disease. However, whether this single …

Trojan horse nanocapsule enabled in situ modulation of the phenotypic conversion of Th17 cells to Treg cells for the treatment of multiple sclerosis in mice

C Shi, J Zhang, H Wang, C Chen, M Han… - Advanced …, 2023 - Wiley Online Library
Th17/Treg imbalance is closely related to the occurrence and development of multiple
sclerosis (MS), and the transdifferentiation of Th17 cells into Treg cells may contribute to the …

[HTML][HTML] Pushing the boundaries of brain organoids to study Alzheimer's disease

J Cerneckis, G Bu, Y Shi - Trends in molecular medicine, 2023 - cell.com
Progression of Alzheimer's disease (AD) entails deterioration or aberrant function of multiple
brain cell types, eventually leading to neurodegeneration and cognitive decline. Defining …

[HTML][HTML] Three-dimensional cell cultures: the bridge between in vitro and in vivo models

O Urzì, R Gasparro, E Costanzo, A De Luca… - International Journal of …, 2023 - mdpi.com
Although historically, the traditional bidimensional in vitro cell system has been widely used
in research, providing much fundamental information regarding cellular functions and …

[HTML][HTML] Brain organoids are new tool for drug screening of neurological diseases

JQ Zhou, LH Zeng, CT Li, DH He… - Neural Regeneration …, 2023 - journals.lww.com
At the level of in vitro drug screening, the development of a phenotypic analysis system with
high-content screening at the core provides a strong platform to support high-throughput …

Toward the next generation of vascularized human neural organoids

M Li, L Gao, L Zhao, T Zou, H Xu - Medicinal research reviews, 2023 - Wiley Online Library
Thanks to progress in the development of three‐dimensional (3D) culture technologies,
human central nervous system (CNS) development and diseases have been gradually …

The blood-brain barrier, a Key Bridge to treat neurodegenerative diseases

Z Hang, L Zhou, C Xing, Y Wen, H Du - Ageing Research Reviews, 2023 - Elsevier
As a highly selective and semi-permeable barrier that separates the circulating blood from
the brain and central nervous system (CNS), the blood-brain barrier (BBB) plays a critical …

[HTML][HTML] Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through

AS Jusop, K Thanaskody, GJ Tye, SA Dass… - Frontiers in Molecular …, 2023 - frontiersin.org
Neurodegenerative diseases are adult-onset neurological conditions that are notoriously
difficult to model for drug discovery and development because most models are unable to …